Filing Flows › Avalo Therapeutics (AVTX) › How it makes money
How Avalo Therapeutics (AVTX) makes money
Avalo Therapeutics (AVTX) made $59K of revenue in the fourth quarter 2025 (Q4 2025), -69% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q4 2025 | % of revenue |
|---|---|---|
| Revenue | $59K | 100.0% |
| Income tax | $130K | 220.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q4 2025 | $59K | -69% |
| Q4 2024 | $192K | -66% |
From Avalo Therapeutics' 10-K filed Mar 23, 2026 (on EDGAR).
Questions
How does Avalo Therapeutics make money?
Avalo Therapeutics (AVTX) made $59K of revenue in the fourth quarter 2025 (Q4 2025), -69% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.